A phase IIb randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis (2012-2015)

Experts

Professor Jeffrey Lipman

Affiliate of UQ Centre for Clinical Research: UQ Centre for Clinical Research; Faculty of Health, Medicine and Behavioural Sciences

Emeritus/Emerita/Emeritx Professor: UQ Centre for Clinical Research; Faculty of Health, Medicine and Behavioural Sciences

Jeffrey Lipman

Jeffrey Lipman

Professor Jason Roberts

Affiliate of Centre for Extracellular Vesicle Nanomedicine: Centre for Extracellular Vesicle Nanomedicine; Faculty of Health, Medicine and Behavioural Sciences

Centre Director of UQ Centre for Clinical Research: UQ Centre for Clinical Research; Faculty of Health, Medicine and Behavioural Sciences

Affiliate of Queensland Cerebral Palsy Rehabilitation and Research Centre: Queensland Cerebral Palsy Rehabilitation and Research Centre; Faculty of Health, Medicine and Behavioural Sciences

Director, UQ Centre for Clinical Research: Faculty of Health, Medicine and Behavioural Sciences

NHMRC Leadership Fellow: Faculty of Health, Medicine and Behavioural Sciences

Jason Roberts

Jason Roberts

Dr Joel Dulhunty

ATH - Associate Professor: Prince Charles Hospital Northside Clinical Unit; Faculty of Health, Medicine and Behavioural Sciences

Joel Dulhunty